# A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis

> **NCT02242435** · PHASE3 · COMPLETED · sponsor: **Ampio Pharmaceuticals. Inc.** · enrollment: 342 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **BIOLOGICAL:** 4 mL injection of Ampion
- **DRUG:** 4 mL Injection of Placebo

## Key facts

- **NCT ID:** NCT02242435
- **Lead sponsor:** Ampio Pharmaceuticals. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2022-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242435, "A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02242435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*